Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
항-SARS-CoV-2 항체의 혈청유병률 및 역학: 우한의 기저 질환 환자를 기반으로 한 종단 연구
Article
[키워드] 95% CI
All participant
All participants
anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibody
Antibody titer
Assessing
asymptomatic patient
asymptomatic patients
baseline
Blood
blood sample
Blood samples
change
Community
COVID-19
Diseases
door
effective
family members
feature
Follow-up
Government
healthcare
Households
Humoral immunity
IgA
IgG
IgG antibodies
IgG antibody
IgG titer
IgG titers
IgM
immunoglobulins
individual
infected with SARS-CoV-2
list
Local
local government
natural infection
Neutralising Antibodies
neutralising antibody
Neutralizing antibody titer
no significant difference
nucleocapsid protein
participant
Participants
Patient
positive
Prevention and control
Protein
provided
questionnaire
Randomly
remained
Research
SARS-CoV-2
SARS-CoV-2 nucleocapsid
selected
serological
Seroprevalence
serum sample
serum samples
significantly
Single natural infection
symptomatic patient
Symptomatic patients
telephone
tested
titer
total antibodies
total antibody
underlying disease
underlying diseases
Underlying diseases.
venous
venous blood
was collected
were assessed
Wuhan
[DOI] 10.1186/s12931-022-02096-5 PMC 바로가기 [Article Type] Article
[DOI] 10.1186/s12931-022-02096-5 PMC 바로가기 [Article Type] Article